View Press Releases

  • Precision NanoSystems NanoAssemblr™ chosen for Horizon 2020 project to develop novel RNA therapeutics

    VANCOUVER, BC, CANADA - Apr 4, 2017 - Precision NanoSystems NanoAssemblr™ platform has been selected for the controlled manufacture of nanomedicines as part of the multinational B-SMART (Brain-Specific, Modular and Active RNA Therapeutics) translational research project

    Apr 4, 2017
  • Repositive Closes Series A Fundraising of £2.5 Million

    CAMBRIDGE, UNITED KINGDOM - Apr 4, 2017 - Repositive, the company that created the world’s largest portal for accessing human genomic research data, has closed a Series A funding round of £2

    Apr 4, 2017
  • Sharp announces £9 million investment

    RHYMNEY, UK - Apr 3, 2017 - Sharp Clinical Services (Sharp), part of UDG Healthcare plc (LON:UDG), has announced a £9 million  investment to fund a new multiple-phase pharmaceutical manufacturing, packaging and distribution facility in Wales

    Apr 3, 2017
  • Ethical Assessment of Clinical Trials Following EU CTR Implementation - Are We Ready for Changes?

    BERLIN, GERMANY - Mar 30, 2017 - Since the publication of the EU Clinical Trial Regulation (CTR) 536/2014 in the Official Journal  a new scheme of Clinical Trial Application (CTA)  has been developed

    Mar 30, 2017
  • Cenduit to Showcase Advanced Solutions at IRT Europe 2017

    DURHAM, NC, UNITED STATES - Mar 29, 2017 -  WHAT:  Cenduit, LLC, the largest interactive response technology (IRT) specialist in the world, is showcasing its solutions and expertise at IRT Europe, April 4-5 in London, England

    Mar 29, 2017
  • Van Andel Research Institute installs world-class microscopes to enable discovery of the molecular basis of disease

    GRAND RAPIDS, MI, UNITED STATES - Mar 28, 2017 - Van Andel Research Institute (VARI) is now home to one of the world’s most powerful microscopes—one that images life’s building blocks in startling clarity and equips VARI’s growing team of scientists to push the limits of discovery in search of new treatments for diseases such as cancer and Parkinson’s

    Mar 28, 2017
  • TECHNIDATA launches new generation TDBactiLink, the middleware for bacteriology laboratories, and dedicated website: www.microbiology-middleware.com

    MONTBONNOT, FRANCE - Mar 28, 2017 -   A cost-effective middleware that brings laboratories to the forefront of technology  TDBactiLink is a dedicated middleware solution for bacteriology laboratories looking to make the most of technological advances and paperless organization without changing their existing laboratory information system (LIS)

    Mar 28, 2017
  • Linguamatics and Dow Jones Partner to Accelerate Pharma Industry Research

    CAMBRIDGE, UK - Mar 28, 2017 - – Market leading NLP text analytics provider Linguamatics today announced a partnership with premium news content provider Dow Jones

    Mar 28, 2017
  • TraceLink and Advanco partner to simplify serialization line management integration

    - Mar 24, 2017 - North Reading, MA (March 23, 2017)—TraceLink Inc., the World’s Largest Track and Trace Network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, today announced a partnership with Advanco to support pharmaceutical manufacturers with the integration of line management and enterprise systems when complying with new serialization regulations

    Mar 24, 2017
  • Recipharm partners with Sato to manufacture product for Japanese market

    KARLSKOGA, SWEDEN - Mar 21, 2017 - Recipharm, the contract development and manufacturing organisation (CDMO), has entered into a long term agreement with Sato Pharmaceutical Co

    Mar 21, 2017
  • Eurofins to invest millions in new UK facility

    LIVINGSTON, SCOTLAND - Mar 21, 2017 - Eurofins Scientific (EUFI.PA), a world leader in bioanalytical testing, has announced plans to establish a new pharmaceutical chemistry and microbiology facility in Livingston, Scotland as part of a £4 million investment

    Mar 21, 2017
  • Recipharm names 2016 International Environmental Award winner

    STOCKHOLM, SWEDEN - Mar 16, 2017 - Recipharm has announced that its 2016 International Environmental Award has been presented to Alistair Boxall, Professor in environmental science at the University of York, for his research into the impact of chemical contaminants on the environment and human health

    Mar 16, 2017
  • MR Solutions introduces 9.4T preclinical MRI imaging solution to cardiovascular sector

    GUILDFORD, UNITED KINGDOM - Mar 16, 2017 - MR Solutions’ new 9.4 tesla cryogen free preclinical scanners created great interest from cardiologists at the 20th Annual Scientific Sessions of the Society for Cardiovascular Magnetic Resonance (SCMR)

    Mar 16, 2017
  • MDI Biological Laboratory to Offer Signature Course in Comparative Regenerative Biology

    BAR HARBOR, ME - Mar 15, 2017 - Why are some animals able to regenerate the form and function of almost any body part? What are the similarities and differences in the genetic circuits for regeneration in these animals? To what extent do humans share these genetic circuits? How can we manipulate these circuits in humans to trigger regeneration of lost or damaged tissues and organs?These are some of the intriguing questions that will be addressed in the MDI Biological Laboratory’s  “REGEN 2017” course in Comparative Regenerative Biology July 29 through Aug

    Mar 15, 2017
  • The Pistoia Alliance Tackles Laboratory Safety with the Launch of the Chemical Safety Library Service

    - Mar 15, 2017 - The Pistoia Alliance Tackles Laboratory Safety with the Launch of the Chemical Safety Library ServiceCollaborative database of previously inaccessible hazardous chemical reactions improves safety for scientists carrying out experiments in the labBoston, 15 March, 2017 - The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, has today announced the launch of the Chemical Safety Library (CSL) Service, which allows hazardous reaction information to be captured, stored and shared, to improve laboratory safety

    Mar 15, 2017
  • Deep 6 AI Wins Enterprise and Smart Data Category at SXSW Accelerator Competition

    PASADENA, CA - Mar 14, 2017 - Deep 6 AI, an artificial intelligence-enabled technology platform for matching patients to clinical trials, took home first prize in the Enterprise and Smart Data category at the 9th annual SXSW Accelerator competition, the marquee event of the South by Southwest® (SXSW®) Conference and Festivals (March 10-19, 2017)  Startup Village®

    Mar 14, 2017
  • MDI Biological Laboratory Completes New Center for Science Entrepreneurship

    BAR HARBOR, ME - Mar 14, 2017 -               Center Inaugurated with New Course on 'Bridging Disciplines' BAR HARBOR, MAINE -- The MDI Biological Laboratory inaugurates its Center for Science Entrepreneurship this week with a new course that will help University of Maine and College of the Atlantic science and engineering undergraduates explore approaches to biomedical research using concepts and tools that promote collaboration across disciplines

    Mar 14, 2017
  • twoXAR Announces Preclinical Proof-of-Concept Data on Novel Liver Cancer Candidate

    PALO ALTO, CA - Mar 14, 2017 - twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical company, today announced that its candidate targeting hepatocellular carcinoma (HCC or Liver Cancer), TXR-311, has shown positive results in cell-based assays

    Mar 14, 2017
  • IDBS extends validated service to the cloud

    BOSTON, US, & GUILDFORD, UNITED KINGDOM - Mar 14, 2017 - After The E-WorkBook Cloud launch earlier this year, IDBS has now enhanced its capabilities by adding a pre-qualified service to the suite, which has been designed to help organizations streamline their compliance processes for good practice (GxP) regulated systems

    Mar 14, 2017
  • NeoGenomics and Definiens Enter Into Agreement to Develop Novel Assays for Clinical Trials & Clinical Testing

    FORT MYERS, FL, UNITED STATES - Mar 13, 2017 - NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, and Definiens, the leader in Tissue Phenomics® solutions from biomarker discovery to meaningful diagnostics, today announced that they have expanded their alliance to develop and automate the analysis of new biomarker assays for clinical trials and routine clinical testing

    Mar 13, 2017